Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 16

3 years ago

BOSTON, March 08, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a…

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

3 years ago

InFoods® IBS LDT validation testing at the CLIA Lab is completed and the product is now being offered commerciallyClinical trial…

Data on Potential Biomarker for Qualigen Therapeutics’ Lead Program QN-302 Published in Peer-Reviewed Journal Molecules

3 years ago

S100P Gene Expression May Be Marker of Anti-Tumor Activity in Pancreatic Cancer In Vivo Models CARLSBAD, Calif., March 08, 2023…

MaxCyte Establishes New Scientific Advisory Board Comprised of Globally Recognized Experts in Cell Engineering Enabling Technology

3 years ago

MaxCyte’s Scientific Advisory Board will provide guidance to shape the technical direction of the company’s innovation initiatives focused on the…

ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product

3 years ago

The global hair restoration market is expected to reach $13.6 billion by 2028LOS ANGELES, March 08, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc.…

aTyr Pharma to Present at March Investor Conferences

3 years ago

SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery…

Replimune to Present at Two Upcoming Investor Conferences

3 years ago

WOBURN, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the…

OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate

3 years ago

MDX-2201 leverages ModeX’s innovative biologics platform to target multiple Epstein-Barr virus (EBV) proteinsEBV is the leading cause of infectious mononucleosis…

Panbela to Host Fourth Quarter and Year End 2022 Earnings Conference Call on March 16, 2023

3 years ago

MINNEAPOLIS, March 08, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for…

KOL Event on Next-Generation Neurotherapeutics: Leveraging the Power of Music and Technology

3 years ago

March 20, 2023 at 11:00 AM ETPORTLAND, Maine, March 08, 2023 (GLOBE NEWSWIRE) -- MedRhythms today announced it will host…